Rx
Chat
Home
›
Drugs: B
›
Beyfortus
Beyfortus
Active Ingredient(s):
Nirsevimab-alip
FDA Approved: *
July 17, 2023
Pharm Company: *
ASTRAZENECA AB
Category:
Antiviral
* May have multiple approval dates, manufacturers, or labelers.
Start a Discussion
Dosage List
Beyfortus 100 mg/ml Intramuscular Injection
NDC:
49281-574
Labeler:
Sanofi Pasteur Inc.
Beyfortus 50 mg/.5ml Intramuscular Injection
NDC:
49281-575
Labeler:
Sanofi Pasteur Inc.
COMMUNITY
Home Page
Drug Forums
Submit a Topic
Health Newsletter
DRUGS
Top Prescription Drugs
Drug Categories
NDC Database
Half Life Calculator
Recent FDA Approvals
ABOUT
Medical Disclaimer
Terms of Use
Privacy Policy
Cookie Manager
Do Not Sell or Share My
Personal Information
DRUG INDEX
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
This website is intended for informational purposes only. It is not meant to be a substitute for medical advice from a healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer.
Copyright © 2005-2024 RxChat.com. All Rights Reserved.
RxChat.com
9878 W Belleview Ave #5000
Denver, CO 80123
United States